Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE HealthCare
GEHC
|
+$3.1B |
| 2 |
Intel
INTC
|
+$1.53B |
| 3 |
Salesforce
CRM
|
+$1.14B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$799M |
| 5 |
Mastercard
MA
|
+$787M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$2.22B |
| 2 |
Toronto Dominion Bank
TD
|
+$2.1B |
| 3 |
PNC Financial Services
PNC
|
+$1.84B |
| 4 |
General Motors
GM
|
+$1.41B |
| 5 |
UnitedHealth
UNH
|
+$1.17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.69% |
| 2 | Healthcare | 16.93% |
| 3 | Consumer Discretionary | 13.35% |
| 4 | Industrials | 12.42% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Danaher
DHR
$144B
| $581M | 0.17% |
2,602,254
+248,406
| +11% | +$56.5M |
|
|
BLD
127
DELISTED
TopBuild
BLD
| $572M | 0.16% |
2,746,336
+64,327
| +2% | +$12.4M |
|
128
Albemarle
ALB
$15.5B
| $559M | 0.16% |
2,527,685
+101
| +0% | +$24.9K |
|
129
Cummins
CMI
$87.4B
| $551M | 0.16% |
2,307,056
-456,599
| -17% | -$111M |
|
130
Haemonetics
HAE
$4.16B
| $551M | 0.16% |
6,653,742
+697,678
| +12% | +$56.5M |
|
131
HDFC Bank
HDB
$119B
| $542M | 0.15% |
16,259,122
+221,696
| +1% | +$7.41M |
|
132
Qorvo
QRVO
$8.66B
| $533M | 0.15% |
5,248,401
-358,227
| -6% | -$36.3M |
|
133
International Flavors & Fragrances
IFF
$21.5B
| $524M | 0.15% |
5,701,298
+3,256,503
| +133% | +$324M |
|
134
Nu Holdings
NU
$66.5B
| $517M | 0.15% |
108,553,608
+22,924,937
| +27% | +$102M |
|
135
United Parcel Service
UPS
$89.4B
| $491M | 0.14% |
2,529,451
+680,707
| +37% | +$125M |
|
136
Alnylam Pharmaceuticals
ALNY
$30B
| $489M | 0.14% |
2,439,596
+1,607,479
| +193% | +$338M |
|
137
Wyndham Hotels & Resorts
WH
$5.49B
| $475M | 0.14% |
7,005,821
-659,467
| -9% | -$48.6M |
|
138
NextEra Energy
NEE
$179B
| $472M | 0.13% |
6,124,511
-7,178,825
| -54% | -$552M |
|
139
Grab
GRAB
$14.7B
| $471M | 0.13% |
156,551,395
+2,974,740
| +2% | +$9.88M |
|
140
Marriott International
MAR
$92.7B
| $455M | 0.13% |
2,739,738
-18,095
| -0.7% | -$3.01M |
|
141
Constellation Brands
STZ
$23.1B
| $454M | 0.13% |
2,009,004
+573,868
| +40% | +$128M |
|
142
SBA Communications
SBAC
$19.7B
| $442M | 0.13% |
1,692,668
-276,951
| -14% | -$76.2M |
|
143
Stanley Black & Decker
SWK
$15.5B
| $438M | 0.12% |
5,432,196
+1,594,872
| +42% | +$134M |
|
|
DHR.PRB
144
DELISTED
Danaher Corporation 5.00% Mandatory Convertible Preferred Stock, Series B
DHR.PRB
| $433M | 0.12% |
339,927
+13,971
| +4% | +$18.1M |
|
145
Dominion Energy
D
$60.1B
| $425M | 0.12% |
7,597,444
-12,093,225
| -61% | -$708M |
|
146
Caterpillar
CAT
$393B
| $415M | 0.12% |
1,812,090
+561
| +0% | +$136K |
|
147
Chubb
CB
$132B
| $413M | 0.12% |
2,129,231
+700,974
| +49% | +$147M |
|
148
Williams-Sonoma
WSM
$28.8B
| $405M | 0.12% |
6,663,380
-1,525,662
| -19% | -$95.3M |
|
149
Exelon
EXC
$46.9B
| $402M | 0.11% |
9,602,158
-5,626,113
| -37% | -$235M |
|
150
Citigroup
C
$232B
| $398M | 0.11% |
8,487,047
+100,870
| +1% | +$4.95M |
|
Similar funds
Capital Research Global Investors's Q1 2023 Portfolio in Review
As of Q1 2023, Capital Research Global Investors held 458 positions worth $350B, up 5.9% from $331B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Capital Research Global Investors's Q1 2023 filing shows 22 new, 178 increased, 161 reduced and 33 closed positions. Its largest new stake was GE HealthCare: 43,443,782 shares worth $3.56B. The largest sale was GE Aerospace, an estimated $2.22B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Capital Research Global Investors's largest Q1 2023 buy was GE HealthCare: 43,443,782 shares worth $3.56B.
- Capital Research Global Investors added most to Salesforce in Q1 2023, an estimated $1.14B increase.
- Capital Research Global Investors's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $2.22B.
- Capital Research Global Investors fully exited First Republic Bank in Q1 2023, selling an estimated $346M.
- Capital Research Global Investors's ten largest holdings make up 27% of its $350B portfolio in Q1 2023.
- Capital Research Global Investors opened 22 new positions and closed 33 in Q1 2023.
- Capital Research Global Investors's portfolio value rose 5.9% quarter-over-quarter to $350B.
Based on Capital Research Global Investors's 13F filing for Q1 2023, filed 15 May 2023.